Estrategias Combinadas en Inmunoterapia Traslacional
ITC
Columbia University Medical Center
Nueva York, Estados UnidosPublikationen in Zusammenarbeit mit Forschern von Columbia University Medical Center (2)
2021
-
OX40 agonist BMS-986178 alone or in combination with nivolumab and/or ipilimumab in patients with advanced solid tumors
Clinical Cancer Research, Vol. 27, Núm. 2, pp. 460-472
2019
-
An integrative approach to inform optimal administration of OX40 agonist antibodies in patients with advanced solid tumors
Clinical Cancer Research, Vol. 25, Núm. 22, pp. 6709-6720